| Literature DB >> 21752269 |
Mathias Holm1, Anna Dahlman-Höglund, Kjell Torén.
Abstract
BACKGROUND: The primary aim of the present study was to investigate if exposure to dust from absorbent hygiene products containing superabsorbent polymer is related to symptoms from the airways and from the eyes. The secondary aim was to estimate the current exposure to superabsorbent polymer among production and maintenance workers in a plant producing hygiene products.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21752269 PMCID: PMC3155498 DOI: 10.1186/1471-2458-11-557
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Concentrations of inhalable dust and super absorbent polymer (SAP) among workers in two plants producing hygiene products.
| Occupations or department | N | Arith-metic | Range | Geometric | Geometric standard | 95% |
|---|---|---|---|---|---|---|
| Inhalable dust, mg/m3 | 41 | 1.37 | 0.17-23.9 | 0.53 | 2.66 | 0.07-3.5 |
| SAP, mg/m3 | 41 | 0.02 | 0.002-0.23 | 0.01 | 2.75 | 0.002-0.09 |
| Inhalable dust, mg/m3 | 19 | 1.64 | 0.14-15.4 | 0.47 | 2.29 | 0.09-2.39 |
| SAP, mg/m3 | 19 | 0.81 | 0.002-10.3 | 0.03 | 2.67 | 0.005-0.24 |
| Inhalable dust, mg/m3 | 37 | 0.40 | 0.05-1.51 | 0.27 | 2.52 | 0.04-1.65 |
| SAP, mg/m3 | 37 | 0.03 | 0.002-0.40 | 0.01 | 3.45 | 0.008-0.11 |
Basic data about the population, separated into all subjects and the overlapping groups of workers exposed to super absorbent polymer (SAP) or paper dust.
| All | Exposed to superabsorbent polymer (SAP)1 | Exposed to paper dust1 | |
|---|---|---|---|
| All | 1043 | 689 | 804 |
| Men | 589 (56.5%) | 414 (60.1%) | 472 (58.7%) |
| Women | 454 (46.5%) | 275 (39.9%) | 332 (41.3%) |
| Age, yrs | 44.8 (11.3) | 42.7 (10.4) | 44.0 (10.8) |
| Never smokers | 523 (50.1%) | 361 (52.4%) | 405 (50.4%) |
| Ex-smokers | 330 (31.7%) | 207 (30.0%) | 254 (31.6%) |
| Current smokers | 190 (18.2%) | 121 (17.6%) | 145 (18.0%) |
| Atopy | 197 (18.9%) | 148 (21.5%) | 160 (19.9%) |
| Physician-diagnosed adult-onset asthma | 71 (6.8%) | 40 (5.8%) | 50 (6.2%) |
| Current asthma | 112 (10.7%) | 72 (10.5%) | 84 (10.5%) |
| Rhinitis | 471 (45.2%) | 322 (46.7%) | 378 (47.0%)3 |
| Nasal blockage | 349 (33.5%) | 252 (36.6%)2 | 283 (35.2%)3 |
| Nasal crusts | 442 (42.4%) | 313 (45.4%)2 | 362 (45.0%)2 |
| Nose-bleeding | 465 (44.6%) | 332 (48.2%)2 | 387 (48.1%)2 |
| Conjunctivitis | 235 (22.3%) | 162 (23.5%) | 188 (23.4%) |
| Hand eczema | 134 (12.9%) | 89 (12.9%) | 104 (12.9%) |
1. Overlapping groups
2. p < 0.01
3. p < 0.05
Basic data about the population, separated into unexposed subjects, subjects exposed either to super absorbent polymer or paper dust and subjects with both exposures.
| No exposure to superabsorbent polymer or paper dust | Only exposed to superabsorbent polymer | Only exposed to paper dust | Exposed to both superabsorbent polymer and paper dust | |
|---|---|---|---|---|
| All | 186 | 53 | 168 | 636 |
| Physician-diagnosed adult-onset asthma | 17 (9.1%) | 4 (7.6%) | 14 (8.3%) | 36 (5.7%)2 |
| Current asthma | 20 (10.8%) | 8 (15.1%) | 20 (11.9%) | 64 (10.1%) |
| Rhinitis | 71 (38.2%) | 22 (41.5%) | 78 (46.4%) | 300 (47.2%)3 |
| Nasal blockage | 46 (24.7%) | 20 (37.7%)1 | 51 (30.4%) | 232 (36.5%)3 |
| Nasal crusts | 61 (32.8%) | 19 (35.9%) | 68 (40.5%) | 294 (46.2%)3 |
| Nose-bleeding | 62 (33.3%) | 16 (30.2%) | 71 (42.3%)2 | 316 (49.7%)3 |
| Conjunctivitis | 35 (18.8%) | 12 (22.6%) | 38 (22.6%) | 150 (23.6%) |
| Hand eczema | 22 (11.8%) | 8 (15.1%) | 23 (13.7%) | 81 (12.7%) |
P-values in comparison with unexposed subjects.
1. p = 0.06
2. p = 0.08
3. p < 0.05
Odds ratios for asthma, current asthma, rhinitis, different nasal symptoms, conjunctivitis and hand eczema in relation to exposure to super absorbent polymer and paper dust.
| Exposure | Exposure to | |||
|---|---|---|---|---|
| Outcome | OR | 95% CI | OR | 95% CI |
| Physician-diagnosed adult-onset | 0.8 | 0.4-1.4 | 0.8 | 0.5-1.6 |
| Current asthma (n = 112) | 1.0 | 0.6-1.7 | 0.9 | 0.5-1.5 |
| Rhinitis (n = 471) | 0.9 | 0.7-1.3 | 1.3 | 0.9-1.9 |
| Nasal blockage (n = 349) | 1.3 | 0.9-1.8 | 1.2 | 0.8-1.7 |
| Nasal crusts (n = 442) | 1.1 | 0.8-1.5 | 1.4 | 1.01-2.1 |
| Nose bleeding (n = 465) | 1.1 | 0.8-1.5 | 1.7 | 1.2-2.4 |
| Conjunctivitis (n = 235) | 1.1 | 0.7-1.6 | 1.2 | 0.8-1.8 |
| Hand eczema (n = 134) | 0.9 | 0.6-1.5 | 1.0 | 0.6-1.7 |
The results are from logistic regression models comprising gender, atopy, smoking, age and both exposure variables. OR = odds ratio. CI = confidence interval.
1. 1 = Yes; 0 = No